Purpose: The Sleep Position Trainer (SPT) is a new option for treating patients with positional obstructive sleep apnea (POSA).
Purpose: To report the durability of voretigene neparvovec-rzyl (VN) adeno-associated viral vector-based gene therapy for RPE65 mutation-associated inherited retinal dystrophy (IRD), including results of a phase 1 follow-on study at year 4 and phase 3 study at year 2.
Edwards Lifesciences announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability
Collegium Pharmaceutical has announced the publication of an analysis of the duration of effect of Xtampza ER (oxycodone extended-release capsules)...
This is a two part, double-blind, randomized, multicenter study to evaluate the regrowth of hair with CTP-543 and subsequent durability of that regrowth following dose reduction in adult patients with moderate to severe alopecia areata.
FDA approves Senza II SCS for pain relief.
Horizon Therapeutics plc announced the initiation of a clinical trial evaluating Krystexxa (pegloticase injection) in combination with methotrexate as a...
Galderma announced new data demonstrating nemolizumab’s long-term and increasing efficacy on skin lesions and other symptoms in prurigo nodularis through to week 52 in the OLYMPIA LTE study